Immunotherapy of hepatocellular carcinoma

"Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death in the United States. Treatment options are limited. Viral hepatitis is one of the major risk factors for HCC, which represents a typical "inflammation-induced" cancer.

Saved in:
Bibliographic Details
Other Authors: Greten, Tim F.
Format: eBook
Language: English
Published: Cham : Springer, 2017.
Subjects:
Liver > Cancer > Immunotherapy.
Immunotherapy.
Cancer > Treatment.
elektronické knihy
electronic books
ISBN: 9783319649580
9783319649573
Physical Description: 1 online resource (x, 267 pages) : illustrations

Cover

Table of contents

LEADER 03245cam a2200409Ii 4500
001 97550
003 CZ-ZlUTB
005 20201031105950.0
006 m o d
007 cr cnu---unuuu
008 171011s2017 sz a ob 001 0 eng d
040 |a YDX  |b eng  |e rda  |e pn  |c YDX  |d N$T  |d EBLCP  |d GW5XE  |d N$T  |d NOC  |d COD  |d COO  |d MERER  |d SNK  |d OCLCQ  |d CAUOI  |d IOG  |d UAB  |d OCLCF  |d OCLCQ  |d KSU  |d U3W  |d WYU  |d LVT  |d UKMGB  |d UKAHL  |d OCLCQ 
020 |a 9783319649580  |q (electronic bk.) 
020 |z 9783319649573 
035 |a (OCoLC)1005856300  |z (OCoLC)1005506780  |z (OCoLC)1005969491 
245 0 0 |a Immunotherapy of hepatocellular carcinoma /  |c Tim F. Greten, editor. 
264 1 |a Cham :  |b Springer,  |c 2017. 
300 |a 1 online resource (x, 267 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a počítač  |b c  |2 rdamedia 
338 |a online zdroj  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
506 |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty 
520 |a "Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death in the United States. Treatment options are limited. Viral hepatitis is one of the major risk factors for HCC, which represents a typical "inflammation-induced" cancer. 
520 |a Immune-based treatment approaches have revolutionized oncology in recent years. Various treatment strategies have received FDA approval including dendritic cell vaccination, for prostate cancer, as well as immune checkpoint inhibition targeting the CTLA4 or the PD1/PDL1 axis in melanoma, lung, and kidney cancer. Additionally, cell-based therapies (adoptive T cell therapy, CAR T cells and TCR transduced T cells) have demonstrated significant efficacy in patients with B cell malignancies and melanoma. Immune checkpoint inhibitors in particular have generated enormous excitement across the entire field of oncology, providing significant benefit to a minority of patients. 
520 |a In this book we provide insights into liver - cancer and immunology. Experts in the field provide an overview of fundamental immunological questions in liver cancer and tumorimmunology, which form the base for immune-based approaches in HCC, which are gaining increasing interest in the community due to first promising results obtained in early clinical trials."--Preface. 
505 0 |a Preface -- Introduction -- Vaccine approaches -- Spontaneous Immune responses to ablative therapies -- Antigen-specific T cell responses. Immune checkpoint inhibitors -- NASH and HCC -- Cytokine activated killer cells -- Sorafenib combination therapy -- Glypican 3 -- Suppressor cells -- Cytokines in HCC pathogenesis and treatment -- Index. 
590 |a SpringerLink  |b Springer Complete eBooks 
650 0 |a Liver  |x Cancer  |x Immunotherapy. 
650 0 |a Immunotherapy. 
650 0 |a Cancer  |x Treatment. 
655 7 |a elektronické knihy  |7 fd186907  |2 czenas 
655 9 |a electronic books  |2 eczenas 
700 1 |a Greten, Tim F. 
856 4 0 |u https://proxy.k.utb.cz/login?url=https://link.springer.com/10.1007/978-3-319-64958-0  |y Plný text 
992 |c NTK-SpringerBLS 
999 |c 97550  |d 97550 

Similar Items